Original Research
Published on 31 Mar 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials
in Multiple Sclerosis and Neuroimmunology
- 11,990 views
- 40 citations























